Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation

Anti-TNF therapy has improved the treatment of inflammatory disease but can predispose to infection and malignancy. Here the authors show an anti-TNF biologic peptide that functionally and selectively targets the TNF-p38 pathway in multiple models of inflammation.

Guardado en:
Detalles Bibliográficos
Autores principales: Violet R. Mukaro, Alex Quach, Michelle E. Gahan, Bernadette Boog, Zhi H. Huang, Xiuhui Gao, Carol Haddad, Suresh Mahalingam, Charles S. Hii, Antonio Ferrante
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/6d8d32e467ee4dd0a9417a3616257e88
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6d8d32e467ee4dd0a9417a3616257e88
record_format dspace
spelling oai:doaj.org-article:6d8d32e467ee4dd0a9417a3616257e882021-12-02T14:39:04ZSmall tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation10.1038/s41467-018-03640-y2041-1723https://doaj.org/article/6d8d32e467ee4dd0a9417a3616257e882018-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-03640-yhttps://doaj.org/toc/2041-1723Anti-TNF therapy has improved the treatment of inflammatory disease but can predispose to infection and malignancy. Here the authors show an anti-TNF biologic peptide that functionally and selectively targets the TNF-p38 pathway in multiple models of inflammation.Violet R. MukaroAlex QuachMichelle E. GahanBernadette BoogZhi H. HuangXiuhui GaoCarol HaddadSuresh MahalingamCharles S. HiiAntonio FerranteNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Violet R. Mukaro
Alex Quach
Michelle E. Gahan
Bernadette Boog
Zhi H. Huang
Xiuhui Gao
Carol Haddad
Suresh Mahalingam
Charles S. Hii
Antonio Ferrante
Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
description Anti-TNF therapy has improved the treatment of inflammatory disease but can predispose to infection and malignancy. Here the authors show an anti-TNF biologic peptide that functionally and selectively targets the TNF-p38 pathway in multiple models of inflammation.
format article
author Violet R. Mukaro
Alex Quach
Michelle E. Gahan
Bernadette Boog
Zhi H. Huang
Xiuhui Gao
Carol Haddad
Suresh Mahalingam
Charles S. Hii
Antonio Ferrante
author_facet Violet R. Mukaro
Alex Quach
Michelle E. Gahan
Bernadette Boog
Zhi H. Huang
Xiuhui Gao
Carol Haddad
Suresh Mahalingam
Charles S. Hii
Antonio Ferrante
author_sort Violet R. Mukaro
title Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
title_short Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
title_full Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
title_fullStr Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
title_full_unstemmed Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
title_sort small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/6d8d32e467ee4dd0a9417a3616257e88
work_keys_str_mv AT violetrmukaro smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT alexquach smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT michelleegahan smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT bernadetteboog smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT zhihhuang smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT xiuhuigao smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT carolhaddad smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT sureshmahalingam smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT charlesshii smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
AT antonioferrante smalltumornecrosisfactorreceptorbiologicsinhibitthetumornecrosisfactorp38signallingaxisandinflammation
_version_ 1718390776094785536